Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Betamarc in CACS in Advanced NSCLC
NCT00535015Phase 2Terminated
- Sponsor
- Anaborex
- Start
- Oct 2007
- Primary completion
- Jun 2008
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 2 trial of BetaMarc in cancer anorexia-cachexia syndrome (CACS), sponsored by Anaborex. Started Oct 2007; status: terminated.
02
Drugs
BetaMarc
03
Conditions
cancer anorexia-cachexia syndrome (CACS)
Beyond the preview
Go deeper on NCT00535015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00535015.